Coronary artery stenting

Catheterization and Cardiovascular Interventions

Volumn 56, Issue 1, 2002, Pages 83-102

  Ashby, Dale T ^a,b   Dangas, George ^a,b   Mehran, Roxana ^a,b   Leon, Martin B ^a,b  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALLOON; COMPARATIVE STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY STENT; DEVICE; HUMAN; INTRAVASCULAR ULTRASOUND; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIES; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; HUMANS; STENTS; TREATMENT OUTCOME; UNITED STATES;

EID: 0036241786     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10209     Document Type: Review

References (165)

1. Coronary transluminal angioplasty
2. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease
3. A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
4. Evolving trends in interventional device use and outcomes: Results from the National Cardiovascular Network (NCN) database
5. Improved hospital outcome with expanded use of coronary stents: Results from NHBLI Dynamic Registry
6. Comparison of three coronary stents: Clinical and angiographic outcome after elective placement in 134 consecutive patients
7. Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses
8. Increased restenosis rate associated with the Microstent compared to the Palmaz Schatz stent in matched coronary lesions
9. A randomised trial of endoluminal reconstruction comparing the Nir stent and the Wallstent in angioplasty of long segment coronary disease: Results of the RENEWAL study
10. Angiographic and clinical restenosis following the use of long coronary Wallstents
11. Six-month clinical and angiographic outcome of the new, less shortening Wallstent in native coronary arteries
12. Long-term clinical outcome after stent implantation in saphenous vein grafts
13. Clinical and angiographic outcome following implantation of the new less shortening Wallstent in aortocoronary vein grafts: Introduction of a second generation stent in the clinical arena
14. Total Endovascular reconstruction of occluded saphenous vein grafts using coronary or peripheral Wallstents
15. Reconstructing diseased vein grafts - Great potential raises old issues
16. Stents covered by autologous venous grafts: Feasibility and immediate and long-term results
17. Implantation of stents covered by autologous arterial grafts in human coronary arteries: A new technique
18. The Jomed covered stent for coronary artery aneurysms and acute perforation: A successful device which needs careful deployment and may not reduce restenosis
19. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model
20. Animal models of human coronary restenosis
21. Vascular pathology of balloon-expandable flexible coil stents in humans
22. The pathology of various mechanical interventional procedures and devices
23. Final results of a randomized trial comparing the Multi-Link stent with the Palmaz-Schatz stent for narrowings in native coronary arteries
24. The Microstent's ability to limit restenosis trial
25. Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries
26. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO) trial
27. Intracoronary stenting for acute and threatened closure complicating transluminal coronary angioplasty
28. Four year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure
29. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous coronary angioplasty: Clinical and angiographic outcomes
30. Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of Benestent-I trial
31. Clinical outcome improvements from coronary stenting: A systemic overview
32. Stent placement for non-STRESS/BENESTENT lesions: A critical review
33. In-stent restenosis: The Washington Hospital Center experience
34. Dealing with in-stent restenosis
35. Impact of vessel wall injury on in-stent restenosis: A serial quantitative angiographic and intravascular ultrasound study
36. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome
37. Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results
38. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
39. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study investigators
40. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
41. Acute and long-term cost implications of coronary stenting
42. Bailout and corrective use of Gianturco-Roubin flex stents after percutaneous transluminal coronary angioplasty: Operator reports and angiographic core lab verification from the National Heart, Lung, and Blood Institiute/New Approaches to Coronary Intervention Registry
43. Coronary stenting for treatment of acute or threatened closure following dissection after coronary balloon angioplasty
44. Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures
45. Can restenosis after angioplasty be predicted from clinical variables?
46. Restenosis after coronary angioplasty: A multivariate statistical model to relate lesion and procedural variables to restenosis
47. Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization
48. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty
49. ACC expert consensus document on coronary artery stents
50. Optimal percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): A randomised trial
51. Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS)
52. Balloon optimization versus stent study (BOSS): Provisional stenting and early recoil after balloon angioplasty
53. A randomized comparison of the effects of gradual inflation at optimum pressure versus stent implantation on early and late outcome
54. Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement: Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II study group
55. The French randomized optimal stenting trial
56. Randomized comparison of elective stent implantation and coronary balloon angioplasty guided by online quantitative angiography and intracoronary Doppler: DESTINI study group (Doppler Endpoint STenting INternational Investigation)
57. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors: Evaluation of platelet IIb/IIIa inhibition in stenting investigators
58. Stents improve late clinical outcomes: Results from the combined (I+II) Stent Restenosis study
59. Real life stenting: A comparison of target vessel revascularization in Benestent-Stress lesions to non-Benestent-Stress lesions
60. Initial and six month outcome of Palmaz-Schatz stent implantation: Stress-Benestent equivalent vs. non-equivalent lesions
61. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting
62. Intimal hyperplasia thickness at follow-up is independent of stent size: A serial intravascular ultrasound study
63. Balloon angioplasty for the treatment of saphenous vein grafts
64. Percutaneous transluminal angioplasty of saphenous vein graft stenosis: Long term follow-up
65. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein graft lesions: CAVEAT-II investigators
66. Excimer laser angioplasty versus balloon angioplasty in saphenous vein bypass grafts: Qualitative angiographic comparison of matched lesions
67. Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years
68. Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting
69. A randomised trial of coronary stenting and balloon angioplasty in the treatment of aortocoronary saphenous vein bypass graft disease
70. Comparison of debulking followed by stenting versus stenting alone for saphenous vein graft aortoostial lesions: Immediate and one-year clinical outcomes
71. Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting
72. Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting
73. In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site
74. Incidence and treatment of "no-reflow" after percutaneous coronary intervention
75. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty: Restenosis Stent Study Group
76. Optimally deployed stents in the treatment of restenotic versus de novo lesions
77. PTCA of chronically occluded coronary arteries
78. Percutaneous transluminal coronary angioplasty for chronic total coronary occlusion
79. Long term luminal narrowing after successful elective coronary angioplasty of total occlusions: A quantitative angiographic analysis
80. Stenting in chronic coronary occlusion (SICCO)
81. Stent implantation versus balloon angioplasty in chronic coronary occlusions: Results from the GISSOC trial - Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche
82. A randomized trial of elective stenting after balloon recanalization of chronic total occlusions
83. Primary stenting versus balloon angioplasty in occluded coronary arteries: The Total Occlusion Study of Canada (TOSCA)
84. Stent or angioplasty after recanalization of chronic coronary occlusions?
85. Mayo-Japan investigation for chronic total occlusions (MAJIC)
86. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
87. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
88. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction
89. Primary mechanical reperfusion in acute myocardial infarction: The United States experience
90. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Gianturco-Roubin in Acute Myocardial Infarction
91. A clinical trial comparing primary stenting of the infarct related artery with optimal primary angioplasty for acute myocardial infarction
92. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction
93. Coronary angioplasty with or without stent implantation for acute myocardial infarction
94. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction
95. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-Day clinical outcome of the French Multicenter Registry
96. Subacute stent thrombosis in the era of IVUS-guided coronary stenting without anticoagulation: Frequency, predictors and clinical outcome
97. Safety and efficacy of angiography-guided stent placement in small native coronary arteries of < 3.0 mm in diameter
98. Angiographic and clinical outcome following coronary stenting of small vessels: A comparison with coronary stenting of large vessels
99. A randomized comparison of elective stenting and balloon angioplasty in the treatment of small coronary arteries
100. Vessel size and long term outcome after coronary stent placement
101. In-hospital results and six-month clinical and angiographic follow-up of coronary stenting in small coronary arteries: Final results of the Bestent in small arteries (BESMART) study
102. Stent to prevent restenosis in small arteries
103. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease: ISAR-SMART Study Investigators
104. Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries
105. Determining appropriate small vessels for stenting by intravascular ultrasound
106. Long-term outcome of patients with very long stents for treatment of diffuse coronary disease
107. Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions
108. Predictive factors of restenosis after coronary stent placement
109. The use of IVUS guided PTCA and spot stenting for the treatment of long lesions: A comparison to traditional stenting
110. The Additional Value of Nir Stent for Treatment of Long Coronary Lesions (ADVANCE) study
111. Coronary angioplasty of bifurcation lesions without protection of large side branches
112. Angioplasty of coronary bifurcation stenoses
113. Placement of coronary stents in bifurcation lesions by the "culotte" technique
114. Coronary stenting of bifurcation lesions using "T" or "reverse Y" configuration with Wiktor stent
115. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions
116. Bifurcation lesions: Two stents versus one stent-immediate and follow-up results
117. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin
118. Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting
119. Treatment of ostial lesions of the left anterior descending coronary artery with Palmaz-Schatz coronary stent
120. Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts
121. Stent placement for ostial left anterior descending coronary artery stenosis: Acute and long-term (2-year) results
122. Comparison of balloon angioplasty versus debulking devices versus stenting in right coronary ostial lesions
123. Unprotected left main coronary artery stenting: Immediate and medium-term outcomes of 140 elective procedures
124. Stenting of unprotected left main coronary artery stenoses: Immediate and late outcomes
125. Intervention of unprotected left main stenosis in high risk patients: Acute and long term results
126. Contemporary percutaneous treatment of unprotected left main coronary stenoses: Initial results from a multicenter registry analysis 1994-1996
127. Impact of stents on clinical outcomes in percutaneous left main coronary artery revascularization
128. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease
129. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: Insights from the Arterial Revascularization Therapy Study (ARTS) trial
130. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance
131. Swine model of coronary restenosis: Effect of a second injury
132. Intravascular ultrasound-guided optimized stent deployment: Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study)
133. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study
134. Can intracoronary ultrasound (ICUS)-guided "stent-like" balloon angioplasty convey a "stent-like" 6-month angiographic and ICUS outcome?
135. Acute and long-term results of an intravascular ultrasound-guided percutaneous transluminal coronary angioplasty/provisional stent implantation strategy
136. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study
137. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk fisk patients: The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)
138. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The clopidogrel aspirin stent international cooperative study (CLASSICS)
139. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
140. Thrombotic thrombocytopenic purpura associated with ticlopidine: A review of 60 cases
141. Thrombotic thrombocytopenic purpura associated with clopidogrel
142. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents
143. Reduction in major adverse cardiac events, including mortality, after stenting using clopidogrel instead of ticlopidine
144. Clopidogrel versus ticlopidine after intracoronary stent placement
145. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation
146. Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting
147. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): A randomised, placebo-controlled trial
148. Do Tirofiban and ReoPro give similar efficacy trial: Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization
149. Late thrombosis following intracoronary brachytherapy
150. Catheter-based radiotherapy to inhibit restenosis after coronary stenting
151. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis
152. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting
153. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: Results of the beta energy restenosis trial (BERT)
154. Intracoronary beta-radiation therapy inhibits recurrence of instent restenosis
155. Inhibition of restenosis with beta-emitting radiotherapy: Report of the proliferation reduction with vascular energy trial (PREVENT)
156. Diabetic patients with in-stent restenosis respond favorably to gamma radiation therapy: Results from a randomized clinical trial
157. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington radiation for in-stent restenosis trial plus 6 months of clopidogrel (WRIST PLUS)
158. Three-year clinical and angiographic follow-up after intracoronary radiation: Results of a randomized clinical trial
159. Endovascular brachytherapy in coronary arteries: The Rotterdam experience
160. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study
161. Inhibition of in-stent restenosis by a drug eluting polymer stent: Pilot trial with 18 month follow-up
162. Coronary stents
163. Coronary stent characteristics